The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II combination study of tifcemalimab with toripalimab in patients with refractory extensive stage small cell lung cancer (ES-SCLC).
 
Ying Cheng
No Relationships to Disclose
 
Jie Wang
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Qiming Wang
Consulting or Advisory Role - Hansoh Pharma
Research Funding - Hansoh Pharma (Inst)
 
Runxiang Yang
No Relationships to Disclose
 
Dongqing Lv
No Relationships to Disclose
 
Bing Xia
No Relationships to Disclose
 
Tienan Yi
No Relationships to Disclose
 
Chong Li
No Relationships to Disclose
 
Xicheng Wang
No Relationships to Disclose
 
Wei Zhang
No Relationships to Disclose
 
Liang Han
No Relationships to Disclose
 
Xiaoqing Liu
No Relationships to Disclose
 
Minjie Shen
Employment - Shanghai Junshi Biosciences
 
Jing Xu
Employment - Shanghai Junshi BioSciences
 
Peng Xue
Employment - Shanghai Junshi BioSciences
 
Weihua Wang
Employment - Shanghai Junshi BioSciences